
Fungal Protein Market (2023-2029)
The Fungal Protein Market is expected to reach $397.5 million by 2029, at a CAGR of 7.6% during the forecast period 2023–2029. Moreover, in terms of volume, the global fungal protein market is expected to reach 23,185 tons by 2029, at a CAGR of 6.2% during the forecast period.
- Published
- May 2023
- Pages
- 176
- Format
- PDF + Excel
- Report ID
- MRFB - 104614
- Base year
- 2022
- 2029 · FORECAST
- $397.5M
- 2029
- $397.5M
- CAGR 2023–2029
- 7.6%
2022 baseline · 2023–2029 forecast at 7.6% CAGR · hover a bar for the value
Key highlights
The Fungal Protein Market is expected to reach $397.5 million by 2029, at a CAGR of 7.6% during the forecast period 2023–2029.
Moreover, in terms of volume, the global fungal protein market is expected to reach 23,185 tons by 2029, at a CAGR of 6.2% during the forecast period.
The fusarium venenatum extract segment is estimated to account for the largest share of the global fungal protein market.
The food & beverage segment is estimated to account for the largest share of the global fungal protein Market.
However, Asia-Pacific is expected to record the highest CAGR of 8.4% during the forecast period 2023–2029. The rapid growth of the fungal protein market in Asia-Pacific is attributed to the rising awareness about health and wellness concerns among the population, growing demand for vegan food products, and increased demand for a protein-rich diet.
In 2022, North America is estimated to account for the largest share of the global fungal protein market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Report summary
| Particulars | Details |
|---|---|
| Page No. | ~176 |
| Format | |
| Forecast Period | 2023-2029 |
| Base Year | 2022 |
| CAGR | 7.6% |
| Market Size (Value) | $397.5 Million |
| Market Size (Volume) | 23,185 tons |
| Segments Covered | By Type · Fusarium Venenatum Extract · Mushrooms · Yeast Extract · By Application · Food & Beverages · Beverages · Bakery · Other Food & Beverages · Animal Nutrition · Poultry Feed · Pig Feed · Aquafeed · Others · Pharmaceuticals · Other Applications · By Geography · North America · U.S. · Canada · Europe · Germany · France · U.K. · Italy · Spain · Rest of Europe · Asia-Pacific · China · Japan · India · Australia · Rest of Asia-Pacific · Latin America · Middle East & Africa |
| Countries/Regions Covered | North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), Latin America, and the Middle East & Africa |
| Key Companies | Koninklijke DSM N.V. (Netherlands), Associated British Foods plc (U.K.), Lesaffre Group (France), Kerry Group plc (Ireland), Lallemand Inc. (Canada), Oriental Yeast Co., Ltd. (Japan), Halcyon Proteins Pty. Ltd. (Australia), AngelYeast Co., Ltd. (China), Van Wankum Ingredients BV (Netherlands), and MYCORENA AB (Sweden). |
Report overview
Segments covered: type, application. Regions: North America, Europe, Asia-Pacific.
The growth of this market is expected to be driven by factors such as the rapidly growing demand for allergen-free foods, rising consumption of processed food, and growing demand for meat-substitute products. Moreover, the rising adoption of yeast extract in the processed food industry is expected to offer significant growth opportunities for players in the fungal protein market. However, factors such as undefined regulatory guidelines are expected to hinder market growth to a certain extent.
The fungal protein comprises fusarium venenatum extract, mushrooms, and yeast extract. Fusarium venenatum is a filamentous fungus used to produce mycoprotein on a commercial scale. Mycoprotein is one of the few solutions to meet the growing global protein demand, environmentally and economically sustainable. Mycoprotein offers the benefit of having a low environmental impact owing to its specific and perfectly mastered manufacturing process. As a result, it is considered a sustainable protein compared to other more resource-intensive and environmentally impactful sources.
Mycoprotein is witnessing demand from the meat substitute sector due to its unique nutritional characteristics. Unlike most plant-based proteins, mycoproteins are complete proteins containing all nine essential amino acids and compare well with other protein sources. The growing instances of soy allergies and wheat gluten intolerance across the globe are causing the mycoprotein-based meat substitutes market to grow as more consumers switch their preferences from soy and wheat to mycoprotein. Thus, the growing preference for mycoprotein-based meat substitutes and the increasing demand for soy-free products are driving the demand for mycoprotein and, thereby, the growth of the global fungal protein market.
Furthermore, some of the key future targets for mycoprotein production aim to turn the production process into a more cyclical one, utilizing wastewater and reusing some of the waste streams, including leftovers from fermentation. A few manufacturers are investing heavily in R&D for the future target of the cyclic process as well as in marketing and category management of the brand.
The growing world population's increased demand for protein and meat substitutes or meat alternative products has led to the development of new food ingredients from alternative protein sources. Currently, protein manufacturers are finding innovative ways to meet the growing demand for alternative proteins. Over the past decade, there has been a growing interest in developing and producing plant, cell-based, and other protein sources-based alternatives to farmed meat. Meat alternatives include fungal protein-based products that look and taste like meat and could potentially play a key role in stimulating dietary change. Plant-based and fungal protein is of immense importance worldwide, leading to the growing interest in its ability to meet the rising demand for protein from non-meat sources, as high meat consumption levels are increasingly being criticized due to ethical and environmental issues.
Furthermore, several studies target processed meat to show the relationship between the consumption of these products and health concerns. The International Agency for Research on Cancer (IARC) has classified processed meat as a carcinogen that causes cancer and red meat as a probable carcinogen that probably causes cancer. As a result, the American Cancer Society has recommended a diet limiting processed and red meat. The American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention recommend choosing beans instead of red and processed meat. Meat alternatives have lower saturated fat than meat (higher saturated fat intake is linked to an increased risk of heart disease). Fungal protein is derived from a fungi-based sustainable food source, has low total and saturated fat levels, and contains very low amounts of cholesterol.
Moreover, mycoprotein can be used to make a variety of substitute meat products, and its naturally meat-like structure gives a cost and texture advantage over plant-based proteins, which have to go through an additional process to reproduce the texture of meat.
Thus, fungal protein is a healthy source of protein compared to conventional meat and offers several social, environmental, and health benefits, driving the demand for fungal protein across the globe.
Major companies in the global fungal protein market have implemented various strategies over the years to expand their product offerings & global footprints and augment their market shares. The key strategies followed by the leading companies in this market were product launches, investments, agreements, collaborations, & partnerships, expansions, and acquisitions. The key players profiled in the global fungal protein market research report are Koninklijke DSM N.V. (Netherlands), Associated British Foods plc (U.K.), Lesaffre Group (France), Kerry Group plc (Ireland), Lallemand Inc. (Canada), Oriental Yeast Co., Ltd. (Japan), Halcyon Proteins Pty. Ltd. (Australia), AngelYeast Co., Ltd. (China), Van Wankum Ingredients BV (Netherlands), and MYCORENA AB (Sweden).
Report infographic

Table of contents
10 chapters · 92 sections · 176 pages · click to expandSegmental analysis
| Segment | Largest share (2023) | Fastest growth (2023–2029) |
|---|---|---|
| By Type | Fusarium Venenatum Extract Protein | Yeast extract protein |
| By Application | Food & Beverage | Pharmaceutical application |
By Type
- The fusarium venenatum extract segment is estimated to account for the largest share of the global fungal protein market.
- The large share of this segment is attributed to the increasing consumer inclination to adopt a healthy diet.
- Moreover, its dynamic properties, such as being rich in fiber and protein and low and saturated fat content, further drive the demand for fusarium venenatum-based fungal protein in the food & beverage industries.
- However, the yeast extract protein segment is projected to grow at the highest CAGR of 10.5% during the forecast period, owing to the growing adoption of yeast extract in animal and human nutrition, growing adoption in free-from products, and its cost-effectiveness.
By Application
- The food & beverage segment is estimated to account for the largest share of the global fungal protein Market.
- The dominant position of this segment is attributed to the growing global food & beverage industry and the increasing adoption of mycoprotein in the food industry due to its cholesterol and satiety benefits and nutritional composition.
- Also, the increasing consumer preference for meat alternatives and the growing awareness and demand for protein-rich sustainable food products further boost the demand for fungal protein in the food & beverage industry.
- However, the pharmaceutical application segment is projected to grow at the highest CAGR of 8.0% during the forecast period due to its eukaryotic and unicellular characteristics and post-translational modification ability.
Geographic analysis
Asia-Pacific
Fastest growthHowever, Asia-Pacific is expected to record the highest CAGR of 8.4% during the forecast period 2023–2029. The rapid growth of the fungal protein market in Asia-Pacific is attributed to the rising awareness about health and wellness concerns among the population, growing demand for vegan food products, and increased demand for a protein-rich diet. Moreover, the growing government initiatives to increase the production of yeast and mushrooms in India and China are expected to provide opportunities for stakeholders operating in this market. Asia-Pacific: Fastest Growing Market
North America
Largest shareIn 2022, North America is estimated to account for the largest share of the global fungal protein market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The large share of this market is attributed to the expanding vegan culture, the ongoing protests against animal cruelty, and an enormous number of health-conscious consumers. Moreover, increasing focus on producing protein using sustainable methods due to the rising environmental concerns and ethical aspects associated with animal protein and technological advancements in the food industry further boost the demand for fungal protein in the region.
Competitive landscape
- Koninklijke DSM N.V. · Netherlands
- Associated British Foods plc (U.K.)
- Lesaffre Group · France
- Kerry Group plc · Ireland
- Lallemand Inc. · Canada
- Oriental Yeast Co., Ltd. · Japan
- Halcyon Proteins Pty. Ltd. · Australia
- AngelYeast Co., Ltd. · China
- Van Wankum Ingredients BV · Netherlands
- MYCORENA AB · Sweden
Frequently asked questions
In terms of value, the global fungal protein market is projected to reach $397.5 million by 2029, at a CAGR of 7.6% during the forecast period.
Cite this report
Meticulous Research. (2023). Fungal Protein Market - Global Opportunity Analysis And Industry Forecast (2023-2029) (Report No. MRFB - 104614). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/fungal-protein-market-5300